首页|黄芪甲苷通过抑制氯化物细胞内通道蛋白4/ADP核糖基化因子6信号通路改善血管紧张素Ⅱ诱导的高血压大鼠模型的心肌损伤

黄芪甲苷通过抑制氯化物细胞内通道蛋白4/ADP核糖基化因子6信号通路改善血管紧张素Ⅱ诱导的高血压大鼠模型的心肌损伤

Astragaloside Ⅳ ameliorates myocardial injury in angiotensin Ⅱ induced hypertension rat model by regulating chloride intracellular channel protein 4/ADP-ribosylation factor 6 signal pathway

扫码查看
目的 探究黄芪甲苷在血管紧张素Ⅱ(Ang Ⅱ)诱导的高血压大鼠模型中的心肌保护作用及其机制.方法 将60只SD大鼠分随机分为6组,每组10只:对照组,模型组,黄芪甲苷低(10 mg/kg)、中(20 mg/kg)、高剂量(50 mg/kg)组和ADP核糖基化因子6(Arf6)特异性抑制剂(NAV-2729)组.建立Ang Ⅱ诱导高血压心肌损伤大鼠模型后给予不同药物或剂量处理2周后,观察各组大鼠左心室舒张末期内径、心脏射血分数及短轴缩短率、心肌病理损伤、心肌细胞凋亡以及相关凋亡蛋白B细胞淋巴瘤因子-2(Bcl-2)及Bcl-2关联X蛋白(Bax)表达情况.另选30只SD大鼠随机分为3组,每组10只:氯化物细胞内通道蛋白4(CLIC4)过表达联合黄芪甲苷组、腺病毒阴性对照联合黄芪甲苷组及腺病毒阴性对照组.先通过尾静脉注射相应腺病毒,再用Ang Ⅱ诱导高血压模型.2周后观察大鼠左心室舒张末期内径、心脏射血分数及短轴缩短率、心肌病理损伤、心肌细胞凋亡情况.结果 与模型组大鼠比较,中剂量和高剂量的黄芪甲苷能够改善Ang Ⅱ诱导的高血压心肌损伤模型大鼠的心脏功能及心肌结构,促进抗凋亡蛋白 Bcl-2 表达(0.36±0.01 比 0.22±0.02,0.78±0.01 比 0.22±0.02;均 P<0.05),抑制 Bax 表达(1.51±0.02 比 2.13±0.03,1.22±0.01 比 2.13±0.03;均 P<0.05).黄芪甲苷通过抑制 CLIC4/Arf6 蛋白表达发挥心肌保护作用,过表达CLIC4则减弱这种保护作用.结论 黄芪甲苷能够改善Ang Ⅱ诱导的高血压大鼠模型中的心肌损伤,可能通过抑制CLIC4/Arf6信号通路实现.
Objective To explore the cardioprotective effect and mechanism of astragaloside Ⅳ(AS-Ⅳ)on angio-tensin Ⅱ(Ang Ⅱ)induced hypertension rat model.Methods Sixty Sprague-Dawley(SD)rats were randomly di-vided into 6 groups,with 10 rats in each group:control group,model group,AS-Ⅳ low dose group(10 mg/kg),AS-Ⅳ medium dose group(20 mg/kg),AS-Ⅳ high dose group(50 mg/kg)and specific inhibitor of ADP-ribosyla-tion factor 6(Arf6)(NAV-2729)group.Rats were treated with different drugs or doses after Ang Ⅱ-induced hyper-tensive myocardial injury models were established.The left ventricular end-diastolic diameter,cardiac ejection frac-tion and fractional shortening,myocardial pathological injury,myocardial apoptosis and the expression of related ap-optotic proteins Bcl-2(B-cell lymphoma-2)and Bax(Bcl-2 associated X)in each group were observed after 2 weeks.The other 30 SD rats were randomly divided into three groups,with 10 rats in each group:chloride intracellular channel protein 4(CLIC4)overexpression combined with AS-Ⅳ group,adenovirus negative control combined with AS-Ⅳ group and adenovirus negative control group.The rats were injected with corresponding adenovirus by tail vein and then Ang Ⅱ-induced hypertensive model was eatablished.The end-diastolic internal diameter of the left ventricle,left ventricular ejection fraction,fractional shortening,myocardial pathological damage,and myocardial apoptosis were observed after 2 weeks.Results Compared with the model group,the middle dose and high dose of AS-Ⅳ could improve the cardiac function and myocardial structure of Ang Ⅱ-induced hypertensive myocardial injury model rats,promote the expression of anti-apoptotic protein Bcl-2(0.36±0.01 vs 0.22±0.02,0.78±0.01 vs 0.22±0.02;both P<0.05)and inhibit the expression of Bax(1.51±0.02 vs 2.13±0.03,1.22±0.01 vs 2.13± 0.03;both P<0.05).AS-Ⅳ exerted myocardial protective effect by inhibiting the expression of CLIC4/Arf6 pro-tein,and overexpression of CLIC4 attenuated this protective effect.Conclusion AS-Ⅳ can ameliorate myocardial inju-ry in Ang Ⅱ-induced hypertension rat model,possibly through inhibiting CLIC4/Arf6 signaling pathway.

astragaloside Ⅳchloride intracellular channel protein 4/ADP-ribosylation factor 6angiotensin Ⅱhypertensionmyocardial injury

巩莎、可海霞

展开 >

安阳职业技术学院护理学院,河南安阳 455000

安阳市人民医院心内三科

黄芪甲苷 氯化物细胞内通道蛋白4/ADP核糖基化因子6 血管紧张素Ⅱ 高血压 心肌损伤

2024

中华高血压杂志
中华预防医学会 福建医科大学

中华高血压杂志

CSTPCD北大核心
影响因子:1.331
ISSN:1673-7245
年,卷(期):2024.32(1)
  • 1
  • 29